RadNet, Inc. (RDNT)
74.69
-2.13
(-2.77%)
USD |
NASDAQ |
Aug 24, 16:00
74.67
-0.02
(-0.03%)
After-Hours: 20:00
RadNet Price to Book Value : 5.359 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 5.359 |
| August 21, 2026 | 5.512 |
| August 20, 2026 | 5.528 |
| August 19, 2026 | 5.420 |
| August 18, 2026 | 5.298 |
| August 17, 2026 | 5.448 |
| August 14, 2026 | 5.478 |
| August 13, 2026 | 5.547 |
| August 12, 2026 | 5.521 |
| August 11, 2026 | 5.478 |
| August 10, 2026 | 5.545 |
| August 07, 2026 | 5.194 |
| August 06, 2026 | 4.891 |
| August 05, 2026 | 4.812 |
| August 04, 2026 | 4.967 |
| August 03, 2026 | 4.793 |
| July 31, 2026 | 4.576 |
| July 30, 2026 | 4.498 |
| July 29, 2026 | 4.547 |
| July 28, 2026 | 4.536 |
| July 27, 2026 | 4.414 |
| July 24, 2026 | 4.418 |
| July 23, 2026 | 4.375 |
| July 22, 2026 | 4.249 |
| July 21, 2026 | 4.439 |
| Date | Value |
|---|---|
| July 20, 2026 | 4.354 |
| July 17, 2026 | 4.462 |
| July 16, 2026 | 4.520 |
| July 15, 2026 | 4.406 |
| July 14, 2026 | 4.505 |
| July 13, 2026 | 4.543 |
| July 10, 2026 | 4.707 |
| July 09, 2026 | 4.731 |
| July 08, 2026 | 4.706 |
| July 07, 2026 | 4.867 |
| July 06, 2026 | 4.945 |
| July 02, 2026 | 4.933 |
| July 01, 2026 | 4.708 |
| June 30, 2026 | 4.425 |
| June 29, 2026 | 4.309 |
| June 26, 2026 | 4.415 |
| June 25, 2026 | 4.362 |
| June 24, 2026 | 4.228 |
| June 23, 2026 | 4.085 |
| June 22, 2026 | 4.053 |
| June 18, 2026 | 3.906 |
| June 17, 2026 | 3.840 |
| June 16, 2026 | 4.108 |
| June 15, 2026 | 4.147 |
| June 12, 2026 | 4.122 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Castle Biosciences, Inc. | 2.172 |
| Lumexa Imaging Holdings, Inc. | 1.851 |
| Quest Diagnostics, Inc. | 3.569 |
| Labcorp Holdings, Inc. | 3.190 |
| OPKO Health, Inc. | 0.9323 |
Price to Book Value Related Metrics
| PS Ratio | 2.550 |
| PEG Ratio | -7.745 |
| Price to Free Cash Flow | 79.93 |
| Price | 74.69 |
| Earnings Yield | -0.37% |
| Market Cap | 5.874B |
| PEGY Ratio | -7.745 |
| Operating PE Ratio | 55.10 |